newsfilter
← Latest News
GlobeNewswire·

Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights

Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights ●Progress in the discovery of small molecule therapeutics to treat neurodevelopmental and neurodegenerative diseases for Rett Syndrome ("Rett"), CDKL5 De